Frazier Life Sciences Management, L.P.

Position in ERAS — Erasca, Inc.

CIK 1892134 PALO ALTO, CA

Position in ERAS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$399,244,541

+$314,691,040 QoQ

Shares Held

24,675,188

+8.6% QoQ

Ownership

7.93%

of shares outstanding

% of Portfolio

10.31%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Frazier Life Sciences Management, L.P. holds $3,799,191,824 across 33 Biotechnology names. ERAS ranks #3 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	7,679,684	$709,449,207
2	NAMS	NewAmsterdam Pharma Co N.V.	16,943,774	$542,370,205
3	ERAS	Erasca, Inc. This page	24,675,188	$399,244,541
4	BBIO	BridgeBio Pharma, Inc.	3,448,139	$256,058,802
5	ARQT	Arcutis Biotherapeutics, Inc.	9,874,511	$232,643,479
6	MBX	MBX Biosciences, Inc.	6,652,013	$198,562,588
7	PHAT	Phathom Pharmaceuticals, Inc.	12,466,489	$138,502,692
8	MAZE	Maze Therapeutics, Inc.	4,567,274	$136,333,128

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$399,244,541	24,675,188	+8.6%	Shares	Sole	2026-05-15
2025-12-31	$84,553,501	22,729,436	0.0%	Shares	Sole	2026-02-13
2025-09-30	$49,550,170	22,729,436	0.0%	Shares	Sole	2025-11-14
2025-06-30	$28,866,383	22,729,436	+0.7%	Shares	Sole	2025-08-14
2025-03-31	$30,928,915	22,575,851	+16.4%	Shares	Sole	2025-05-15
2024-12-31	$48,673,134	19,391,687	0.0%	Shares	Sole	2025-02-18
2024-09-30	$52,939,305	19,391,687	+19.6%	Shares	Sole	2024-11-15
2024-06-30	$38,270,269	16,216,216	—	Shares	Sole	2024-08-15
No filing history on record for this holder in this stock.